Role of glycated hemoglobin in the care of diabetes mellitus

dc.creatorCabral, Caroline Almeida
dc.creatorRolim Neto, Modesto Leite
dc.creatorTeixeira, Saulo Araujo
dc.date.accessioned2013-10-24T16:15:23Z
dc.date.accessioned2018-07-04T16:00:28Z
dc.date.available2013-10-24T16:15:23Z
dc.date.available2018-07-04T16:00:28Z
dc.date.created2013-10-24T16:15:23Z
dc.date.issued2012
dc.identifierHEALTHMED, SARAJEVO, v. 6, n. 9, supl., Part 1-2, pp. 3020-3022, JUL-DEC, 2012
dc.identifier1840-2291
dc.identifierhttp://www.producao.usp.br/handle/BDPI/35860
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1630376
dc.description.abstractIntroduction: Persistently high glycemic levels are extremely harmful to the organism and can lead patients to several complications of diabetes mellitus. Glycated hemoglobin represents the glycemic levels for what patient is chronically exposed. Methods: Two virtual databases were surveyed in two languages: Portuguese and English. 12 articles were selected and reviewed. Results and discussion: The HbA1c is used since 1958 in the assessment of glycemic control in diabetic patients. It is formed by a chemical reaction between hemoglobin A and acarbohydrate. Each percentage point of glycated hemoglobin represents approximately 35mg/dL in patient's averageglycemia. Conclusion: The glycated hemoglobin should be measured at least twice per year in patients with diabetes in general. In case of change of hypoglycemic therapy, this frequency should be doubled.
dc.languageeng
dc.publisherDRUNPP-SARAJEVO
dc.publisherSARAJEVO
dc.relationHEALTHMED
dc.rightsCopyright DRUNPP-SARAJEVO
dc.rightsclosedAccess
dc.subjectGLYCATED HEMOGLOBIN
dc.subjectDIABETES MELLITUS
dc.subjectCOMPLICATIONS
dc.subjectGLYCEMIA
dc.titleRole of glycated hemoglobin in the care of diabetes mellitus
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución